Protection of mice from lethal Escherichia coli infection by chimeric human bactericidal/permeability-increasing protein and immunoglobulin G1 Fc gene delivery

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 2, 2007, Pages 724-731

  Chen, Jindong ^a,b   Li, Chengyao ^c   Guan, Yuanzhi ^d   Kong, Qingli ^a   Li, Chen ^a   Guo, Xianghua ^a   Chen, Qinghua ^a   Jing, Xuefang ^a   Lv, Zhe ^a   An, Yunqing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CEFUROXIME; CYTOKINE; ENDOTOXIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 2; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CHO CELL; CONTROLLED STUDY; DISEASE MODEL; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; MOUSE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SEROTYPE; SURVIVAL RATE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CYTOKINES; ENDOTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENE THERAPY; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS;

EID: 33846580479     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00360-06     Document Type: Article

References (38)

1. Alexander, S., J. Bramson, R. Foley, and Z. Xing. 2004. Protection from endotoxemia by adenoviral-mediated gene transfer of human bactericidal/permeability-increasing protein. Blood 103:93-99.
2. 23-Fcγ1 recombinant protein prokaryotic expression vector. Chin. Med. Sci. J. 17:140-147.
3. Anderson, W. F. 1998. Human gene therapy. Nature 392:25-30.
4. Balague, C., J. Zhou, Y. Dai, R. Alemany, S. F. Josephs, G. Andreason, M. Hariharan, E. Sethi, E. Prokopenko, H. Y. Jan, Y. C. Lou, D. Hubert-Leslie, L. Ruiz, and W. W. Zhang. 2000. Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. Blood 95:820-828.
5. Balk, R. A. 2000. Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations. Crit. Care Clin. 16:179-192.
6. Beamer, L. 2002. Human BPI: one protein's journey from lab into clinical trials. ASM News 68:543-548.
7. Bessis, N., F. J. Garcia Cozar, and M. C. Boissier. 2004. Immune responses to gene therapy vectors: influence on vector function and effectors mechanisms. Gene Ther. 11(Suppl. 1):S10-S17.
8. Buning, H., F. M. Braun-Falco, and M. Hallek. 2004. Progress in the use of adeno-associated viral vectors for gene therapy. Cells Tissues Organs 177:139-150.
9. Buning, H., S. A. Nicklin, L. Perabo, M. Hallek, and A. H. Baker. 2003. AAV-based gene transfer. Curr. Opin. Mol. Ther. 5:367-375.
10. Dahlberg, P. S., R. D. Acton, R. J. Battafarano, M. E. Uknis, C. A. Ratz, J. W. Johnston, J. R. Haseman, B. H. Gray, and D. L. Dunn. 1996. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion. J. Surg. Res. 63:44-48.
11. Elsbach, P., and J. Weiss. 1998. Role of the bactericidal/ permeability-increasing protein in host defence. Curr. Opin. Immunol. 10:45-49.
12. Gazzano-Santoro, H., J. B. Parent, L. Grinna, A. Horwitz, T. Parsons, G. Theofan, P. Elsbach, J. Weiss, and P. J. Conlon. 1992. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect. Immun. 60:4754-4761.
13. Gray, P. W., G. Flaggs, S. R. Leong, R. J. Gumina, J. Weiss, C. E. Ooi, and P. Elsbach. 1989. Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J. Biol. Chem. 264:9505-9509.
14. Hildinger, M., A. Auricchio, G. Gao, L. Wang, N. Chirmule, and J. M. Wilson. 2001. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J. Virol. 75:6199-6203.
15. Horwitz, A. H., S. D. Leigh, S. Abrahamson, H. Gazzano-Santoro, P. S. Liu, R. E. Williams, S. F. Carroll, and G. Theofan. 1996. Expression and characterization of cysteine-modified variants of an amino-terminal fragment of bactericidal/permeability-increasing protein. Protein Expr. Purif. 8:28-40.
16. Hubsch, A. P., A. T. Casas, and J. E. Doran. 1995. Protective effects of reconstituted high-density lipoprotein in rabbit gram-negative bacteraemia models. J. Lab. Clin. Med. 126:548-558.
17. Kochanek, S., G. Schiedner, and C. Volpers. 2001. High-capacity 'gutless' adenoviral vectors. Curr. Opin. Mol. Ther. 3:454-463.
18. Lazaron, V., and R. A. Barke. 1999. Gram-negative bacterial sepsis and the sepsis syndrome. Urol. Clin. N. Am. 26:687-699.
19. Levy, S. B., and B. Marshall. 2004. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10:s122-s129.
20. Li, C., J. Li, Z. Lv, X. H. Guo, Q. H. Chen, Q. L. Kong, and Y. Q. An. 2006. Protection of mice from lethal endotoxemia by chimeric human BPI-Fcγ1 gene delivery. Cell. Mol. Immunol. 3:221-225.
21. Lieber, A., D. S. Steinwaerder, C. A Carlson, and M. A. Kay. 1999. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes. J. Virol. 73:9314-9324.
22. Mannion, B. A., J. Weiss, and P. Elsbach. 1990. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli. J. Clin. Investig. 85:853-860.
23. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1545-1554.
24. Mitani, K., and S. Kubo. 2002. Adenovirus as an integrating vector. Curr. Gene Ther. 2:135-144.
25. Ooi, C. E., J. Weiss, M. E. Doerfler, and P. Elsbach. 1991. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability increasing protein of human neutrophils. J. Exp. Med. 174:649-655.
26. Riedemann, N. C., R. F. Guo, and P. A. Ward. 2003. Novel strategies for the treatment of sepsis. Nat. Med. 9:517-524.
27. Sakhuja, K., P. S. Reddy, S. Ganesh, F. Cantaniag, S. Pattison, P. Limbach, D. B. Kayda, M. J. Kadan, M. Kaleko, and S. Connelly. 2003. Optimization of the generation and propagation of gutless adenoviral vectors. Hum. Gene Ther. 14:243-254.
28. Sorensen, O., T. Bratt, A. H. Johnsen, M. T. Madsen, and N. Borregaard. 1999. The human antibacterial cathelicidin hCAP-18 is bound to lipoproteins in plasma. J. Biol. Chem. 274:22445-22451.
29. Spink, J., and D. Geddes. 2004. Gene therapy progress and prospects: bringing gene therapy into medical practice: the evolution of international ethics and the regulatory environment. Gene Ther. 11:1611-1616.
30. Vincent, J. L., Q. Sun, and M. J. Dubois. 2002. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin. Infect. Dis. 34:1084-1093.
31. Wang, Z., H. I. Ma, J. Li, L. Sun, J. Zhang, and X. Xiao. 2003. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther. 10:2105-2111.
32. 106-138-immunoglobulin G in sepsis. J. Infect. Dis. 188:1382-1393.
33. Weiss, J., and I. Olsson. 1987. Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils. Blood 69:652-659.
34. 2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J. Clin. Investig. 90:1122-1130.
35. Weiss, J., P. Elsbach, I. Olsson, and H. Odeberg. 1978. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J. Biol. Chem. 253:2664-2672.
36. Wu, X. B., X. Y. Dong, and Z. J. Wu. 2001. A novel method for purification of recombinant adeno-associated virus vectors in large-scale. Chin. Sci. Bull. 46:485-489.
37. Wu, Z. J., X. B. Wu, H. Cao, X. Y. Dong, H. Wang, and Y. D. Hou. 2001. A novel and high efficient production system for recombinant adeno-associated virus vector. Sci. China Ser. C 31:423-430.
38. Wu, Z. J., X. B. Wu, and Y. D. Hou. 2000. Construction of a series of adeno-associated virus vectors and their expression of b-galactosidase gene. Chin. J. Virol. 16:1-6.